Science & Evidence
Two decades of peer-reviewed neuroscience
Where the claims made across this site are substantiated: validation against established clinical tests, across more than ten conditions, and at population scale.
20+
Years of research
200+
Peer-reviewed studies
10+
Conditions validated
What the evidence shows
Each point is supported by peer-reviewed research, summarised in the sections below.
Agrees with established clinical tests
Results align with trusted neuropsychology tests, including the MoCA, RBANS, ACE-III, and ADAS-Cog.
Detects what screening tools miss
Picks up milder and earlier problems in people who score as normal on common screens.
Reflects changes in the brain
Scores track brain structure on MRI and early disease markers, sometimes before symptoms appear.
Remote testing as reliable as the clinic
People assessed at home, unsupervised, produce results comparable to supervised testing.
Consistent over repeated testing
Minimal practice effects, retest reliability of 0.88 over 18 months, and a clear threshold for meaningful change.
Fair and precise scoring
Results are adjusted for age, education, language, and device, and separate thinking ability from motor impairment.
Population validation
Validated across populations
Cognitron has been used across a wide variety of conditions and in high-performing cohorts. Each person's results are compared with a large normative dataset from the Great British Intelligence Test, adjusted for age, sex, education, first language, and device.
Tasks avoid words unless they are measuring language, so assessment is fairer across cultures, languages, and education levels.
Conditions assessed
One platform across many conditions
Cognitron has been used to assess cognition in specialist patient groups, healthy adults, and high-performing occupational cohorts.
Brain injury
- Traumatic brain injury (acute and chronic)
- Stroke
- Autoimmune limbic encephalitis
- Normal pressure hydrocephalus
Neurodegeneration
- Alzheimer's disease and dementia
- Amyloid and phospho-tau positivity
- Parkinson's disease
- REM sleep behaviour disorder
- Multiple sclerosis
Psychiatry, sleep, and infection
- Schizophrenia
- Chronic insomnia
- COVID-19 and Long COVID
Healthy and high-performing
- Occupational performance
- Population-scale studies
Population validation evidence
Validated on multiple conditions
From specialist patient groups to population samples: the studies behind the conditions above.
| Condition | Study | Who was tested | Key finding |
|---|---|---|---|
| Alzheimer's disease | Del Giovane et al. 2026 | 31 people with Alzheimer's disease | Separated Alzheimer's from healthy ageing with 94% accuracy (AUC 0.94), with a distinct memory and language profile |
| Preclinical Alzheimer's disease | Del Giovane et al. 2025 | 255 cognitively healthy adults aged about 70 | Slower memory responses predicted amyloid positivity (odds ratio 1.79) before any symptoms |
| Normal pressure hydrocephalus | Del Giovane et al. 2026 | 26 people with normal pressure hydrocephalus | Separated hydrocephalus from healthy ageing (AUC 0.90), and scores predicted walking speed |
| Traumatic brain injury | Del Giovane et al. 2023 | 126 people with TBI and 84 controls | Distinguished injury severity better than standard clinical scales, with the same results remotely as in person |
| Stroke | Gruia et al. 2025 | 90 stroke survivors, and 171 followed for up to two years | Found deficits in patients who scored normal on the MoCA, and separated cognitive ability from hand motor impairment |
| Autoimmune limbic encephalitis | Shibata et al. 2024 | 21 patients and 54 controls | Found visuospatial and language deficits the ACE-III missed, linked to hippocampal volume on MRI |
| Parkinson's disease and REM sleep behaviour disorder | Bălăeţ et al. 2024 | 59 people with Parkinson's, 54 with RBD, and 50 controls | Found deficits in memory, language, attention, and executive function where the MoCA showed no group differences |
| Multiple sclerosis | Lerede et al. 2025 | 4,526 members of the UK MS Register | Identified a distinct MS subtype with selective cognitive impairment |
| COVID-19 and Long COVID | Hampshire et al. 2024 | 112,964 adults in England | Detected small but measurable deficits, largest in people with unresolved symptoms (-0.42 SD) and those admitted to intensive care (-0.35 SD) |
| Controlled SARS-CoV-2 infection | Trender et al. 2024 | 36 healthy volunteers followed for a year | Detected subtle cognitive changes in infected compared with uninfected participants |
| Occupational performance | Sharpe et al. 2024 | 111 working lifeguards | Working memory was linked to real-world drowning detection (r = 0.53) |
Full references are listed under Publications below.
Comparative evidence
Compared with standard clinical tests
Cognitron has been compared directly with the clinician-administered tests used in memory clinics, neurology services, clinical trials, and research.
| Standard test | Agreement with Cognitron | What Cognitron added |
|---|---|---|
| MoCA (10-minute clinic screen) | Moderate to very strong, depending on the condition (r = 0.41 to 0.86) | Found deficits the MoCA scored as normal in stroke, Parkinson's disease, and REM sleep behaviour disorder, and distinguished TBI severity better |
| RBANS (30-minute battery) | Very strong shared variance (r = 0.86 and 0.81) | Distinguished TBI severity better than the standard scales, of which only one RBANS subscale showed any difference |
| ACE-III (20-minute clinic screen) | Moderate to strong, depending on the condition (r = 0.57 to β = 0.69) | Found visuospatial and language deficits the ACE-III missed, as a 15-minute remote assessment |
| ADAS-Cog (30 to 45 minutes with a trained assessor) | Strong (β = -0.76) | Delivered as a 15-minute remote assessment, without a clinic visit or trained assessor |
Published in
Publications
Key studies by topic
A selection from the peer-reviewed studies that use Cognitron. Key studies come first in each topic. Open a topic to see the rest.
Neurodegeneration and dementia
Cognitron separated Alzheimer's disease from healthy ageing with 94% accuracy, predicted amyloid positivity in cognitively healthy adults before any symptoms, and found deficits in Parkinson's disease and REM sleep behaviour disorder where the MoCA showed no group differences.
-
In Parkinson's disease and REM sleep behaviour disorder, a 20-minute battery found deficits in memory, language, attention, and executive function where the MoCA showed no group differences.
Bălăeţ et al. · npj Digital Medicine · 2024
-
Remote cognitive tests predict neurodegenerative biomarkers in the Insight 46 cohort
In 255 cognitively healthy adults aged about 70, slower responses on a memory task predicted amyloid positivity (odds ratio 1.79) and tracked brain shrinkage over two years.
Giovane MD et al. · Alzheimer's & Dementia · 2025
-
Digital cognitive phenotyping for differential diagnosis and monitoring in neurological conditions
A 15-minute online battery separated Alzheimer's disease (AUC 0.94) and normal pressure hydrocephalus (AUC 0.90) from healthy ageing, offering a scalable adjunct to standard testing.
Del Giovane M, Giunchiglia V, David MCB, Kolanko MA, Trender WR, Hellyer PJ, Kaur H, Sharp DJ, Carswell C, Malhotra PA, Hampshire A · Annals of Clinical and Translational Neurology · 2026
Show all 11 studies Show fewer
-
Linking cognitive and behavioral reserve: Evidence from the CAN-PROTECT study
Guan DX et al. · Alzheimer's & Dementia: Translational Research & Clinical Interventions · 2024
-
Mudalige D et al. · Public Health · 2025
-
Bălăeţ et al. · Frontiers in Neurology · 2024
-
Online46: Online cognitive assessments in elderly cohorts-The British 1946 birth cohort case study
Cai Z et al. · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2025
-
Martina Del Giovane et al. · Alzheimers & Dementia · 2023
-
Packer A et al. · Frontiers in Dementia · 2023
-
Pupil-linked arousal, cortical activity, and cognition in Alzheimer's disease
David MCB et al. · Brain Communications · 2025
-
Online assessment and monitoring of cognitive decline in neurological conditions
Annalaura Lerede et al. · Journal of Neurology, Neurosurgery & Psychiatry · 2022
Traumatic brain injury
In traumatic brain injury, Cognitron distinguished injury severity better than standard clinical scales, gave the same results remotely as in person, and revealed when people overestimated their own performance.
-
Detected processing speed, attention, working memory, and executive deficits after moderate to severe TBI, distinguished injury severity better than standard clinical scales, and gave the same results remotely as in clinic.
Martina Del Giovane et al. · eClinicalMedicine · 2023
-
People with traumatic brain injury overestimated their performance despite scoring worse than controls, with all testing done remotely on their own smartphones.
Niall J Bourke et al. · Neuropsychological Rehabilitation · 2023
-
Amy E Jolly et al. · Brain · 2020
Show all 5 studies Show fewer
-
Lennon MJ et al. · Journal of Neurology, Neurosurgery & Psychiatry · 2025
-
Current and prospective roles of magnetic resonance imaging in mild traumatic brain injury
Sassani M et al. · Brain Communications · 2025
Stroke
After stroke, Cognitron found deficits in patients the MoCA scored as normal, and separated cognitive ability from hand motor impairment over up to two years of follow-up.
-
Validation of the IC3 stroke battery: high test-retest reliability, equivalent results supervised and unsupervised, and minimal learning effects across repeated sessions.
Gruia DC et al. · Assessment · 2025
-
In 171 stroke survivors, hand motor impairment distorted standard scores on 10 tasks. Cognitron's corrected measures were not distorted and matched pen-and-paper tests more closely.
Gruia DC et al. · eClinicalMedicine · 2025
Multiple sclerosis
One of the world's largest objective studies of cognition in multiple sclerosis (4,526 people) identified a previously unrecognised subtype. Retest reliability over 18 months was r = 0.88.
-
4,526 members of the UK MS Register: a previously unrecognised MS subtype, reproduced in an independent second sample (r = 0.93 for accuracy, 0.88 for speed).
Lerede A et al. · Nature Communications · 2025
-
Yu M et al. · Nutrients · 2025
COVID-19 and Long COVID
Cognitron remotely assessed 112,964 adults in England after COVID-19, detecting small but measurable deficits, and detected subtle cognitive change in a controlled SARS-CoV-2 human challenge study.
-
Cognitive deficits in people who have recovered from COVID-19
Adam Hampshire et al. · eClinicalMedicine · 2021
-
Cognition and Memory after Covid-19 in a Large Community Sample
Remote assessment of 112,964 adults in England found small but measurable deficits after COVID-19, largest in people with unresolved symptoms and those admitted to intensive care.
Hampshire et al. · New England Journal of Medicine · 2024
-
Nathan J Cheetham et al. · eClinicalMedicine · 2023
Show all 18 studies Show fewer
-
Adam Hampshire et al. · eClinicalMedicine · 2022
-
Changes in memory and cognition during the SARS-CoV-2 human challenge study
In a controlled SARS-CoV-2 human challenge study, a baseline-corrected composite score distinguished infected from uninfected volunteers over a year of follow-up.
Trender et al. · eClinicalMedicine · 2024
-
Wood et al. · Nature Medicine · 2024
-
Rapid vigilance and episodic memory decrements in COVID-19 survivors
Sijia Zhao et al. · Brain Communications · 2022
-
Adam Hampshire et al. · Nature Communications · 2021
-
Post-traumatic stress disorder symptoms in COVID-19 survivors: online population survey
Samuel R Chamberlain et al. · British Journal of Psychiatry open · 2021
-
Taquet et al. · The Lancet Psychiatry · 2024
-
Bland et al. · Scientific Reports · 2024
-
Adam Hampshire et al. · Comprehensive Psychiatry · 2022
-
Adam Hampshire et al. · Interface Focus · 2021
-
Maria Bălăeţ et al. · Frontiers in Psychiatry · 2023
-
Bălăeţ M et al. · Comprehensive Psychiatry · 2025
-
Maria Bălăeţ et al. · Frontiers in Psychology · 2023
-
Chiu C, Hampshire A · eClinicalMedicine · 2025
-
Shil RSK et al. · Scientific Reports · 2025
Mental health
-
Kang et al. · Comprehensive Psychiatry · 2024
-
Schweizer et al. · Psychological Medicine · 2024
-
Bălăeţ M et al. · Journal of Psychopharmacology · 2025
Brain imaging
Cognitron scores track brain structure: smaller hippocampal volume was linked to lower scores in autoimmune limbic encephalitis, and in 34,927 UK Biobank participants the regions that predicted ability matched those linked to language and memory.
-
In autoimmune limbic encephalitis, found visuospatial and language deficits the ACE-III missed, with scores linked to hippocampal volume on MRI (r = 0.67).
Kengo Shibata et al. · eClinicalMedicine · 2024
-
Dissociating frontoparietal brain networks with neuroadaptive Bayesian optimization
Romy Lorenz et al. · Nature Communications · 2018
-
Eyal Soreq et al. · Nature Communications · 2021
Show all 4 studies Show fewer
-
The optimisation of functional brain network dynamics when learning to perform complex tasks
Parkin BL et al. · Neuropsychologia · 2025
Assessment, scoring, and performance
Cognitron's IDoCT scoring separates cognitive ability from visuo-motor speed, device lag, and speed-accuracy trade-offs, validated on data from 388,757 adults. Scores also relate to real-world performance.
-
Cognition and lifeguard detection performance
In 111 working lifeguards, working memory was linked to real-world drowning detection (r = 0.53).
Benjamin T. Sharpe et al. · Applied Cognitive Psychology · 2024
-
Using data from 388,757 adults, the IDoCT method separates cognitive ability from device and visuo-motor latencies, non-specific processes, and speed-accuracy trade-offs.
Giunchiglia et al. · npj Digital Medicine · 2024
-
Neural correlates of cognitive ability and visuo-motor speed: validation of IDoCT on UK Biobank data
Applied to 34,927 UK Biobank participants, IDoCT improved test-retest reliability (r = 0.77 vs 0.66) and produced ability and speed measures linked to distinct brain regions.
Giunchiglia V, Curtis S, Smith S, Allen N, Hampshire A · Imaging Neuroscience · 2024
Show all 5 studies Show fewer
-
A large-scale, cross-sectional investigation into the efficacy of brain training
Adam Hampshire et al. · Frontiers in Human Neuroscience · 2019
-
Ghai S et al. · The Gerontologist · 2025
Further research
-
Defining brain fog across medical conditions
Denno P, Zhao S, Husain M, Hampshire A · Trends in Neurosciences · 2025
-
Richard Daws et al. · Frontiers in Psychology · 2017
-
Jeggan Tiego et al. · Assessment · 2023
Show all 13 studies Show fewer
-
Koychev I et al. · BMJ Open · 2024
-
Brain health concerns in former rugby players: clinical and cognitive phenotypes
Parker TD et al. · Brain · 2025
-
Corbett A et al. · Journal of the American Medical Directors Association · 2025
-
Inga Usher et al. · British Medical Journal · 2021
-
Conceptualising compulsivity through network analysis: A two-sample study
Chang Liu et al. · Comprehensive Psychiatry · 2023
-
Liu C et al. · Journal of Medical Internet Research · 2025
-
Del Giovane M et al. · Frontiers in Neuroscience · 2024
-
Mew BG et al. · Neuropsychologia · 2025
-
Telomere length and cognitive changes in 7,877 older UK adults of European ancestry
Packer A et al. · Frontiers in Aging · 2024
-
Malkowski OS et al. · International Journal of Behavioral Nutrition and Physical Activity · 2025
Interested in our research on a particular topic?
Our research library is extensive. Tell us what you're looking into and we'll point you to the most relevant work.